Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Bianchi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|March 5, 2024
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infectionRoberta Sciarra, Michele Merli, Caterina Cristinelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2024
End of induction [<sup>18</sup>F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trialLuca Guerra, Stephane Chauvie, Federico Fallanca, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
Blood Advances|June 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular LymphomaBarbara Botto, Carola Boccomini, Andrea Evangelista, et al.
Lupus Science & Medicine|May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohortGreta Hulej, Federico Arru, Benedetta Bianchi, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|March 5, 2024
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infectionRoberta Sciarra, Michele Merli, Caterina Cristinelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2024
End of induction [<sup>18</sup>F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trialLuca Guerra, Stephane Chauvie, Federico Fallanca, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
Blood Advances|June 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular LymphomaBarbara Botto, Carola Boccomini, Andrea Evangelista, et al.
Lupus Science & Medicine|May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohortGreta Hulej, Federico Arru, Benedetta Bianchi, et al.
Pageof 4